FDA Drug Recalls

Recalls / Class II

Class IID-0137-2023

Product

Cromolyn Sodium Ophthalmic Solution, USP 4%, 10mL per bottle, Rx Only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. NDC: 17478-291-11

Affected lot / code info
Lot: 0G75A, 0G12A, EXP 6/30/2023; 0H50A, EXP 7/31/2023; 0J88A, EXP 8/31/2023; 1D98A, EXP 3/31/2024; 1E31A, EXP 4/30/2024; 1D97A, EXP 3/31/2024; 1H14A, EXP 7/31/2024;

Why it was recalled

CGMP Deviations:

Recalling firm

Firm
Akorn, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
5605 Centerpoint Ct Ste A, N/A, Gurnee, Illinois 60031-5278

Distribution

Quantity
188,550 bottles
Distribution pattern
Nationwide in the USA

Timeline

Recall initiated
2022-10-13
FDA classified
2023-01-13
Posted by FDA
2023-01-25
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0137-2023. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls